Wilder RL - Search Results

1

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG; Protégé Trial Investigators. Sherry N, et al. Among authors: wilder rl. Lancet. 2011 Aug 6;378(9790):487-97. doi: 10.1016/S0140-6736(11)60931-8. Epub 2011 Jun 28. Lancet. 2011. PMID: 21719095 Free PMC article. Clinical Trial.

2

Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis.

Pillemer S, Gulko P, Ligier S, Yarboro C, Gourley M, Goldbach-Mansky R, Siegel R, Hirsch R, Pucino F, Tilley B, Wilder RL. Pillemer S, et al. Among authors: wilder rl. J Rheumatol. 2003 Jan;30(1):41-3. J Rheumatol. 2003. PMID: 12508388 Clinical Trial.

3

High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.

Davis JC Jr, Fessler BJ, Tassiulas IO, McInnes IB, Yarboro CH, Pillemer S, Wilder R, Fleisher TA, Klippel JH, Boumpas DT. Davis JC Jr, et al. J Rheumatol. 1998 Sep;25(9):1694-704. J Rheumatol. 1998. PMID: 9733448 Clinical Trial.

4

Immunologic parameters of response in patients with rheumatoid arthritis treated with cyclosporin A.

Yocum DE, Wilder RL, Dougherty S, Klippel JH, Pillemer S, Wahl S. Yocum DE, et al. Among authors: wilder rl. Arthritis Rheum. 1990 Sep;33(9):1310-6. doi: 10.1002/art.1780330902. Arthritis Rheum. 1990. PMID: 2119587

5

Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.

Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR. Torpy DJ, et al. Among authors: wilder rl. Arthritis Rheum. 2000 Apr;43(4):872-80. doi: 10.1002/1529-0131(200004)43:4<872::AID-ANR19>3.0.CO;2-T. Arthritis Rheum. 2000. PMID: 10765933 Free article.

6

Hormonal supplementation as treatment for cyclical rashes in patients with systemic lupus erythematosus.

Pando JA, Gourley MF, Wilder RL, Crofford LJ. Pando JA, et al. Among authors: wilder rl. J Rheumatol. 1995 Nov;22(11):2159-62. J Rheumatol. 1995. PMID: 8596162

7

Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis.

Kanik KS, Yarboro CH, Naparstek Y, Plotz PH, Wilder RL. Kanik KS, et al. Among authors: wilder rl. Arthritis Rheum. 1996 Jun;39(6):1027-9. doi: 10.1002/art.1780390621. Arthritis Rheum. 1996. PMID: 8651966 Clinical Trial.

8

Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis.

Kanik KS, Hagiwara E, Yarboro CH, Schumacher HR, Wilder RL, Klinman DM. Kanik KS, et al. Among authors: wilder rl. J Rheumatol. 1998 Jan;25(1):16-22. J Rheumatol. 1998. PMID: 9458197

9

Association of HLA alleles and clinical features in patients with synovitis of recent onset.

El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR Jr. El-Gabalawy HS, et al. Among authors: wilder rl. Arthritis Rheum. 1999 Aug;42(8):1696-705. doi: 10.1002/1529-0131(199908)42:8<1696::AID-ANR19>3.0.CO;2-K. Arthritis Rheum. 1999. PMID: 10446870 Free article.

10

Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study.

Yocum DE, Klippel JH, Wilder RL, Gerber NL, Austin HA 3rd, Wahl SM, Lesko L, Minor JR, Preuss HG, Yarboro C, et al. Yocum DE, et al. Among authors: wilder rl. Ann Intern Med. 1988 Dec 1;109(11):863-9. doi: 10.7326/0003-4819-109-11-863. Ann Intern Med. 1988. PMID: 3190040 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page